Brand

Forest Pharmaceuticals Inc Recalls

6 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Forest Pharmaceuticals Inc.

6Total Recalls
0Critical
324,493Units Affected
Sep 26, 2014Most Recent
All Recalls

Every Forest Pharmaceuticals Inc Recall

Sorted by most recent. Click any recall for full details.

6 recalls
High RiskFDA
Forest Pharmaceuticals Inc
Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Fore...
Oral Drugs·94,584 affected·Sep 26, 2014
High RiskFDA
Forest Pharmaceuticals Inc
Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Fo...
Oral Drugs·92,544 affected·Jun 19, 2014
High RiskFDA
Forest Pharmaceuticals Inc
Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pha...
Oral Drugs·21,875 affected·May 12, 2014
RecallFDA
Forest Pharmaceuticals Inc
Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, N...
Oral Drugs·156 affected·Nov 13, 2013
Medium RiskFDA
Forest Pharmaceuticals Inc
Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuti...
Oral Drugs·111,384 affected·Nov 13, 2013
RecallFDA
Forest Pharmaceuticals Inc
Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titr...
Oral Drugs·3,950 affected·Nov 13, 2013